Formoterol dry-powder inhalation - Innovata

Drug Profile

Formoterol dry-powder inhalation - Innovata

Alternative Names: Eformoterol Clickhaler; Eformoterol dry-powder inhalation - Innovata Biomed; Eformoterol dry-powder inhalation - ML Laboratories; Formoterol Clickhaler; Formoterol dry-powder inhalation - Innovata Biomed

Latest Information Update: 18 Mar 2015

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Innovata
  • Developer Vectura
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 24 Jul 2013 Biomarkers information updated
  • 19 Jan 2007 Innovata has been acquired by Vectura
  • 30 Sep 2005 Launched for Asthma in Europe (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top